Progress of cellular immunotherapy modified with chimeric antigen receptor targeting epidermal growth factor receptor and its mutants / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 138-141, 2017.
Artigo
em Chinês
| WPRIM
| ID: wpr-507490
ABSTRACT
Epidermal growth factor receptor (EGFR), an important target for tumor targeted therapy, is overexpressed / mutated in the majority of tumors. Immune cells modified by chimeric antigen receptor , including T cells, NK cells and so on, is a new technology in recent years, which has showed an unique advantage in the treatment of malignant tumors. In this paper, the research progress of T cells and NK cells modified with chimeric antigen targeting for EGFR and its mutants will be reviewed.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Cancer Research and Clinic
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS